| Mar 12 2019 |
Pennsylvania Direct Malt or Brewed Beverage Shipper License |
Stark & Stark |
| Mar 11 2019 |
HHS Proposes Changes to the Discount Safe Harbor Framework to Realign Incentives and Put Downward Pressure on Drug Prices |
Squire Patton Boggs (US) LLP |
| Mar 11 2019 |
Protecting Your Brewery, Brew Pub or Distillery’s Trade Secrets, Confidential Information and Customers From Former Employees |
Stark & Stark |
| Mar 11 2019 |
Are the Bankruptcy Courts Available for the Cannabis Industry? |
Ward and Smith, P.A. |
| Mar 11 2019 |
FSIS Issues Draft Guidance to Industry for Responding to Consumer Complaints |
Keller and Heckman LLP |
| Mar 9 2019 |
JRC Opens Calls for the Nanobiotechnology Laboratory |
Bergeson & Campbell, P.C. |
| Mar 8 2019 |
McDermottPLUS Check-Up: March 8, 2019 |
McDermott Will & Schulte LLP |
| Mar 8 2019 |
Reassessment of Styrene by EFSA on the Horizon |
Keller and Heckman LLP |
| Mar 8 2019 |
Massachusetts’ Highest Court Upholds Record Fine Against Beer Distributor for Pay-To-Play Scheme But Overturns Fine for Bar that Accepted Kickbacks |
McDermott Will & Schulte LLP |
| Mar 8 2019 |
European Commission Opens Public Consultation on the Evaluation of FCMs |
Keller and Heckman LLP |
| Mar 8 2019 |
USDA and FDA Provide Additional Details on Joint Regulation of Cell-Cultured Meat |
Keller and Heckman LLP |
| Mar 8 2019 |
Clarity on the Horizon for CBD Food Products? FDA Commissioner Indicates a Path Forward |
Pierce Atwood LLP |
| Mar 7 2019 |
Market Confusion on CBD and Hemp; FDA Commissioner Resigns amid Congressional Pressure for Federal Guidance |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 7 2019 |
Device Modernization Series: In Vitro Clinical Tests |
Mintz |
| Mar 7 2019 |
FDA Warns of Asbestos Contamination in Certain Cosmetics |
Keller and Heckman LLP |
| Mar 6 2019 |
What to Expect at FDA Following Commissioner Gottlieb's Departure |
Mintz |
| Mar 6 2019 |
FDA Commissioner Scott Gottlieb Resigns |
Keller and Heckman LLP |
| Mar 5 2019 |
FDA Releases Second Draft Guidance to Support Development of Novel Nicotine Replacement Therapies |
Keller and Heckman LLP |
| Mar 5 2019 |
2018 Farm Bill Legalizes Hemp, but Obstacles to Sale of CBD Products Remain |
Much Shelist, P.C. |
| Mar 5 2019 |
Federal Government’s Restrictions on Production, Location, and Use of Plants for the Production of Distilled Spirits |
Stark & Stark |
| Mar 5 2019 |
FDA Takes New Steps to Curtail Youth Access to Tobacco Products and E-Cigarettes |
Keller and Heckman LLP |
| Mar 4 2019 |
OIG Evaluates Remote Patient Monitoring Arrangement |
Epstein Becker & Green, P.C. |
| Mar 4 2019 |
Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing |
Mintz |
| Mar 4 2019 |
Second Circuit Rejects Total Wine Challenge of Connecticut Pricing Laws |
McDermott Will & Schulte LLP |
| Mar 4 2019 |
New Jersey Leaders Agree to Compromise on Cannabis Tax |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Mar 4 2019 |
Final Rule Regarding the Labeling of Bioengineered Foods |
Polsinelli PC |
| Mar 4 2019 |
Trends from the Industrial Hemp Summit |
Ward and Smith, P.A. |
| Mar 4 2019 |
Supreme Court Update: Nutraceutical Corp. v. Lambert (No. 17-1094), Garza v. Idaho (No. 17-1026), Madison v. Alabama (No. 17-7505), Jam v. International Finance Corp. (No. 17-1011), Yovino v. Rizo (No. 18-272) |
Wiggin and Dana LLP |
| Mar 4 2019 |
Putative Class Action Filed Against Walmart, Costco, Amazon and Others Alleging Coffee is Falsely Labeled as “Kona” |
Keller and Heckman LLP |
| Mar 2 2019 |
The Farm Bill’s Impact on Hemp and CBD – and How Some States are Reacting |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 1 2019 |
March 2019: Where Are We Now With 340B? |
Mintz |
| Mar 1 2019 |
Analysis: How the EU legal framework is being adapted to accommodate new food proteins |
Keller and Heckman LLP |
| Mar 1 2019 |
This Week’s Cannabis Highlights |
Keller and Heckman LLP |
| Feb 28 2019 |
What Does the Future Hold for Drug Pricing? |
Mintz |
| Feb 28 2019 |
Nestlé’s Non-Disclosure of Child and Slave Labor Issues on Packaging Not Deceptive or Unfair, Massachusetts Federal Court Holds |
Proskauer Rose LLP |
